|
Index of reports
> Cases with Respiratory Failure (9)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Thalomid (Thalidomide) where reactions include respiratory failure. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Thalomid side effects in male
Reported by a physician from United States on 2012-06-01
Patient: male
Reactions: Myelofibrosis, Respiratory Failure
Adverse event resulted in: death
Drug(s) suspected as cause:
Thalomid
Possible Thalomid side effects in male
Reported by a physician from United States on 2012-05-18
Patient: male
Reactions: Myelofibrosis, Respiratory Failure
Adverse event resulted in: death
Drug(s) suspected as cause:
Thalomid
Possible Thalomid side effects in female
Reported by a physician from United States on 2012-05-01
Patient: female
Reactions: Respiratory Failure, Renal Failure Chronic, Infectious Peritonitis
Adverse event resulted in: death
Drug(s) suspected as cause:
Thalomid
Dosage: 200 milligram
Administration route: Oral
Start date: 2005-04-01
End date: 2005-01-01
Thalomid
Dosage: 200 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2005-01-01
End date: 2005-01-01
Thalomid
Dosage: 100 milligram
Administration route: Oral
Start date: 2010-11-01
End date: 2010-01-01
Thalomid
Dosage: 100 milligram
Administration route: Oral
Start date: 2011-01-01
End date: 2011-01-01
Possible Thalomid side effects in female
Reported by a physician from United States on 2012-03-07
Patient: female
Reactions: Respiratory Failure
Adverse event resulted in: death
Drug(s) suspected as cause:
Thalomid
Possible Thalomid side effects in male
Reported by a physician from United States on 2012-03-07
Patient: male
Reactions: Respiratory Failure
Adverse event resulted in: death
Drug(s) suspected as cause:
Thalomid
Possible Thalomid side effects in 65 year old
Reported by a individual with unspecified qualification from United States on 2012-03-05
Patient: 65 year old
Reactions: Renal Failure, Tumour Lysis Syndrome, Respiratory Failure, Disseminated Intravascular Coagulation, Anaemia, Lung Infiltration, Thrombocytopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Dexamethasone
Dosage: 40 milligram
Indication: Natural Killer-Cell Lymphoblastic Lymphoma
Start date: 2009-11-02
Bortezomib
Dosage: 1 milligram/sq. meter
Indication: Natural Killer-Cell Lymphoblastic Lymphoma
Start date: 2009-11-02
Thalomid
Dosage: 50 milligram
Administration route: Oral
Indication: Natural Killer-Cell Lymphoblastic Lymphoma
Start date: 2009-11-02
Possible Thalomid side effects in female
Reported by a physician from United States on 2012-03-01
Patient: female
Reactions: Respiratory Failure, Multiple Myeloma
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Thalomid
Dosage: 150 milligram
Administration route: Oral
Start date: 2012-01-01
Thalomid
Dosage: 150 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-10-01
End date: 2012-01-01
Thalomid
Dosage: 100 milligram
Administration route: Oral
Start date: 2011-12-01
Other drugs received by patient: Adriamycin PFS; Dexamethasone; Velcade; Vincristine
Possible Thalomid side effects in female
Reported by a physician from United States on 2011-12-22
Patient: female
Reactions: Renal Failure, Respiratory Failure, Multiple Myeloma
Adverse event resulted in: death
Drug(s) suspected as cause:
Thalomid
Possible Thalomid side effects in male
Reported by a physician from United States on 2011-10-25
Patient: male
Reactions: Myelofibrosis, Respiratory Failure
Adverse event resulted in: death
Drug(s) suspected as cause:
Thalomid
|
